Skip to content
2000
Volume 13, Issue 4
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Marine ecosystems constitute a huge reservoir of biologically active secondary metabolites. Consequently during the last past few decades, several marine-derived molecules have been approved for anticancer treatment or are under clinical trials. This review reports the present state of the art of the sixteen molecules approved or currently on the clinical pipeline for anticancer chemotherapy. The molecules are classified according to their current status in the phase (approved / phase IV / phase III / phase II / phase I) and data are updated to April 2012.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/1871520611313040010
2013-05-01
2025-04-09
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/1871520611313040010
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test